Stock screener

INVA

Conviction 33HealthcareScan · Tue, Sep 8, 2026
INVA$21.34+0.02%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 675.93K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Innoviva, Inc.PHARMACEUTICAL PREPARATIONSwww.inva.com ↗
Price21.34
Change+0.02%
Gap-1.69%
Rel volume2.59×
Avg volume643.89K
Avg $ vol13.59M
SMA 2021.09
SMA 5021.42
SMA 20021.78
Price vs 50-0.39%
Price vs 200-2.02%
MA stackbearish
50/200 cross—
Supertrenddown · 22.18
RSI (14)53
MACD hist0.07
MACD cross—
Stoch %K / %D64 / 65
ADX (14)10
+DI / −DI18 / 18
RSI divergence—
MACD divergenceBearish
ATR %+2.14%
ADR %1.73%
52w high24.24
52w low16.67
From 52w high-11.98%
Above 52w low+27.98%
New 52w highNo
SqueezeOn · 18d
Bollinger width4.12%
%B0.78
Donchian pos68.76%
Donchian high21.70
Donchian low20.54
AVWAP (52w high)22.27
vs AVWAP high-4.21%
AVWAP (52w low)21.49
vs AVWAP low-0.72%
OBV trendUp
Chaikin MF (20)0.09
Today vs 20d2.59×
Avg vol (14d)675.92K
Avg vol (20d)643.89K
Avg $ vol (20d)13.59M
Market cap1.54B
RS 3m (vs SPY)-9.71%
RS 6m (vs SPY)-17.72%
RS line new highNo
Trend template3/8
Technical rank41.2
1 week+2.72%
1 month+4.02%
3 months-4.46%
6 months-4.41%
1 year+4.17%
YTD+7.37%
P/E—
P/B1.25
P/S3.75
P/FCF7.87
EPS3.30
Div yield—
ROE—
ROA—
Debt/Eq0.22
Current16.01
EV/EBITDA7.01
Gross margin74.80%
Net margin—
Rev growth14.67%
EPS growth—
Price target40.67
Target upside90.63%
Analyst ratingBuy
Institutional115.31%
Ent. value1.24B
Revenue119.59M
Net income4.43M
Gross profit90.62M
Free cash flow195.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out73.81M
Employees159
ListedTue, Oct 5, 2004
Free float69.7M
Float %94.1%
Short interest6.86M
Days to cover9.2d
Short volume61.3%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.59 vs $0.56
Last surprise+5.4% beat
Setup gradeD
Conviction33 / 100
Pattern quality—
Tech rank41.2 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance22.28
Support20.44
Days since event—
Candle confirm—
News sentiment—

Financials as of Thu, Mar 31, 2016 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Breaking out now
    Jun 10 – Jun 12
    3 scans
  2. Setting up
    Jun 16 – Aug 25
    7 scans

Congress activity

Disclosed STOCK Act trades in INVA · 2 recent

All disclosures →
MemberSideAmount
George Whitesides
George Whitesides
house · D · CA · traded 2025-03-25
Sell$250K–$500K
George Whitesides
George Whitesides
house · D · CA · traded 2025-03-24
Sell$50K–$100K

Insider activity

SEC Form 4 transactions in INVA · 4 buys · 6 sells

InsiderSideShares
Basso Stephen
Chief Financial Officer · Common Stock · 2026-08-20
Tax558
Raifeld Pavel
Chief Executive Officer · Common Stock · 2026-08-20
Tax1.13K
Zhen Marianne
Chief Accounting Officer · Common Stock · 2026-08-20
Tax1.13K
Raifeld Pavel
Chief Executive Officer · Common Stock · 2026-05-20
Tax1.13K
Basso Stephen
Chief Financial Officer · Common Stock · 2026-05-20
Tax559
Zhen Marianne
Chief Accounting Officer · Common Stock · 2026-05-20
Tax1.13K
Raifeld Pavel
Chief Executive Officer · Common Stock · 2026-05-15
Grant1.12K
Basso Stephen
Chief Financial Officer · Common Stock · 2026-05-15
Grant1.12K
Linden Josephine
Director · Non-statutory Stock Option · 2026-05-18
Grant9.17K
Linden Josephine
Director · Common Stock · 2026-05-18
Grant5.73K

SEC filings

EDGAR filings in INVA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.